Nano Financial Statements From 2010 to 2025
| VNTH Stock | USD 0.0002 0.00 0.00% |
Check Nano Mobile financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nano Mobile's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nano financial statements analysis is a perfect complement when working with Nano Mobile Valuation or Volatility modules.
Nano |
Nano Mobile Healthcare Company Return On Asset Analysis
Nano Mobile's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Nano Mobile Return On Asset | -15.78 |
Most of Nano Mobile's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nano Mobile Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Nano Mobile Healthcare has a Return On Asset of -15.778. This is 80.32% higher than that of the Health Care Technology sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Nano Mobile Healthcare Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nano Mobile's current stock value. Our valuation model uses many indicators to compare Nano Mobile value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nano Mobile competition to find correlations between indicators driving Nano Mobile's intrinsic value. More Info.Nano Mobile Healthcare is rated first in return on asset category among its peers. It is rated first in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nano Mobile by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nano Mobile's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Nano Mobile Financial Statements
Investors use fundamental indicators, such as Nano Mobile's revenue or net income, to determine how well the company is positioned to perform in the future. Although Nano Mobile's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Nano Mobile Healthcare, Inc. operates as a mobile health technology company in the United States. Nano Mobile Healthcare, Inc. is a subsidiary of Nanobeak, LLC. Nano Mobile operates under Health Information Services classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Nano Pink Sheet
Nano Mobile financial ratios help investors to determine whether Nano Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nano with respect to the benefits of owning Nano Mobile security.